Drug developer Novavax Inc said on Monday it has completed enrolling 30,000 volunteers in a late-stage study of its COVID-19 vaccine in the United States and Mexico. The company said…

Read more »

The post Novavax Completes Enrolling 30,000 People in U.S. Trial of COVID-19 Vaccine appeared first on Hamodia.

In related news:

  1. Trump, Biden Spoke by Phone About Coronavirus Outbreak
  2. Trump Says That FDA ‘Deep State’ Slowing COVID Vaccine Trials
  3. States Clamp Down as Coronavirus Hospitalizations Surge
  4. Public Health Programs see Surge in Students Amid Pandemic
  5. Virus Cases Continue Climbing in U.S.